Skip to main navigation Skip to search Skip to main content

Application of induced pluripotent stem cell technology to the study of hematological diseases

  • Mailin Li
  • , Pasquale Cascino
  • , Simone Ummarino
  • , Annalisa Di Ruscio

Research output: Contribution to journal › Review article › peer-review

Abstract

The burst of reprogramming technology in recent years has revolutionized the field of stem cell biology, offering new opportunities for personalized, regenerative therapies. The direct reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) has provided an invaluable tool to study and model a wide range of human diseases. Here, we review the transforming potential of such a strategy in research and in therapies applicable to the hematology field.

Original languageEnglish
Article number7
JournalCells
Volume6
Issue number1
DOIs
Publication statusPublished - 8 Mar 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Blood diseases
  • Cancer
  • Regenerative medicine
  • Reprogramming

Fingerprint

Dive into the research topics of 'Application of induced pluripotent stem cell technology to the study of hematological diseases'. Together they form a unique fingerprint.

Cite this